Pain management practices operate at the intersection of HIPAA and a broader regulatory framework around controlled substances. Prescription drug monitoring program data, urine drug screen results, opioid prescribing records, and — for practices that also provide SUD treatment — 42 CFR Part 2 records all require careful compliance management. The sensitivity of this information, and the consequences of unauthorized disclosure, make it particularly important to have documented controls.
PHI Risks Specific to Pain Management Practices
Controlled substance prescribing records. Records documenting opioid and other controlled substance prescriptions link patient identity to a specific drug, dose, and prescriber. These records are PHI and are also subject to DEA record-keeping requirements. Access should be limited to staff with a direct clinical or billing need, and electronic records require audit logging under 45 CFR 164.312(b).
Prescription drug monitoring program (PDMP) access. Most states require pain management practices to query the PDMP before prescribing certain controlled substances. The PDMP query results — and the act of querying — generate records that are PHI. The practice should have a documented policy for who is authorized to query the PDMP, how results are stored, and under what circumstances results may be shared with other providers.
Urine drug screen results. UDS results documenting the presence or absence of controlled substances or illicit drugs are PHI. If they reflect a patient’s substance use, they may also implicate 42 CFR Part 2 protections if the practice is a federally assisted SUD treatment program. The practice must be clear on which regulatory framework applies to each category of record.
42 CFR Part 2 intersection. Part 2 applies to records of patients receiving SUD treatment at a “federally assisted” program. “Federally assisted” is defined specifically at 42 CFR 2.12: it includes programs that receive federal funding directly (grants, contracts), are authorized, certified, or licensed by a federal agency, are conducted by a federal agency, or are tax-exempt under 26 U.S.C. 501(c)(3). Importantly, Medicaid reimbursement alone does not automatically make a program federally assisted for Part 2 purposes — the analysis depends on the specific funding stream and the program’s structure. However, DEA registration and some SAMHSA grant programs can trigger Part 2. Practices that provide any SUD treatment services should have their regulatory counsel determine definitively whether Part 2 applies and, if so, maintain separate compliance documentation. Part 2 imposes more restrictive re-disclosure rules than HIPAA and requires patient-specific written consent for most disclosures, including to other treating providers.
Procedure records. Pain management practices perform interventional procedures — nerve blocks, spinal injections, neuromodulation — that generate anesthesia records, procedure notes, and imaging. These records move between the practice, the facility, and the patient’s other treating providers. Each transmission is a PHI disclosure with applicable Privacy Rule requirements.
Common Compliance Gaps
Pain management practices most often identify these gaps: no formal policy distinguishing which records are subject to 42 CFR Part 2 versus HIPAA alone, and PDMP access that is not logged in a way that produces an auditable record of who queried what and when.
What PHIGuard Provides
PHIGuard provides pain management practice administrators with a compliance management platform that does not require a compliance officer to operate. The platform includes:
- Workforce training tracking with per-employee timestamps per §164.530(b)
- Incident log with guided breach risk assessment per 45 CFR 164.402
- BAA tracking for billing companies, laboratory vendors, and procedure facility partners
- Compliance task templates for annual risk analysis and policy review cycles
- Immutable audit trail on all compliance records
Pricing is per practice, not per provider. Essentials at $99/month, Clinic at $249/month, Group at $499/month. See current plan details and tier limits, or visit the HIPAA compliance overview for the regulatory framework applicable to pain management practices.